[New methods of treatment of purulent cerebrospinal meningitis in children].
D000367:Age Factors; D000667:Ampicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000145:classification / Q000627:therapeutic use*; D002228:Carbenicillin / Q000627:therapeutic use; D002512:Cephalothin / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003023:Cloxacillin / Q000627:therapeutic use; D003091:Colistin / Q000627:therapeutic use; D005260:Female; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007612:Kanamycin / Q000627:therapeutic use; D008297:Male; D008581:Meningitis / Q000188:drug therapy*; D008722:Methods
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D007612:Kanamycin; D000667:Ampicillin; D002228:Carbenicillin; D003023:Cloxacillin; D002512:Cephalothin; D003091:Colistin
W sprawie nowych metod leczenia ropnego zapalenia opon mózgowo-rdzeniowych u dzieci